GlassScriptPhysician profile
Josiah B Ward
NPI 1952641664
$907.26
in general payments reported to CMS, 2019-2025
15 companies · $276 in 2025
The $276 reported for 2025 was more than what 82% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $203 · 2022: $71.96 · 2023: $151 · 2024: $205 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $632.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $203.60 | 2021-2025 | Azstarys |
| Paratek Pharmaceuticals, INC. | $125.00 | 2025 | Nuzyra |
| Penumbra, INC. | $108.30 | 2025 | Indigo System |
| Merck Sharp & Dohme LLC | $94.85 | 2021-2024 | Gardasil 9, Vaxelis, Gardasil |
| Takeda Pharmaceuticals U.S.A., INC. | $81.27 | 2021 | |
| Sobi, INC | $66.39 | 2021-2023 | |
| Glaxosmithkline, LLC. | $43.85 | 2021 | |
| Sanofi Pasteur INC. | $39.27 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $23.86 | 2024 | Austedo Xr |
| Medical Device Business Services, INC. | $22.94 | 2024 | Stratafix |
| Organon LLC | $22.91 | 2023 | Nexplanon |
| Agios Pharmaceuticals, INC. | $20.33 | 2025 | Pyrukynd |
| Ironshore Pharmaceuticals INC. | $19.66 | 2023 | Jornay Pm |
| Xeris Pharmaceuticals, INC. | $18.03 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $17.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Josiah Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.